vaccine

    By Melly Alazraki

    | 5:30PM 12/14/2009
    The San Antonio Breast Cancer Symposium, held Dec. 9-13, brought mostly good news for breast cancer patients and drugmakers. And that's a welcome development: Aside from non-melanoma skin cancer, breast cancer is the most common form of cancer in women and the second-leading cause of cancer death...

    By Melly Alazraki

    | 4:30PM 12/03/2009
    It's bad enough that the H1N1 swine flu pandemic has caused such widespread public anxiety, and it's worse that the vaccine has become its own source of concern, whether due to the shortage or spurious fears about its safety. Now, the bottom-feeders known as phishing scammers are exploiting the...

    By Melly Alazraki

    | 4:50PM 12/02/2009
    A biotech with a novel method of making vaccines, has a promising swine flu drug. So far, so good, but it's hardly a lock

    By Melly Alazraki

    | 4:50PM 11/16/2009
    Not two months after the Swiss start-up Cytos's experimental anti-smoking vaccine failed in a mid-stage study, Nabi Biopharmaceuticals (NABI) and GlaxoSmithKline (GSK) have signed a licensing agreement for Nabi's own anti-smoking vaccine, NicVAX. The deal, which could potentially be worth more than...

    By Melly Alazraki

    | 10:30AM 11/11/2009
    The U.S. may worry about having enough H1N1 vaccine to protect its population from swine flu, but at least it's getting precious doses. Many developing countries, which can't afford the sometimes expensive medication, don't have any at all. That may change soon. The U.K.'s GlaxoSmithKline (GSK)...

    By Lauren Cooper

    | 7:00AM 11/10/2009
    Asian stocks rose Tuesday. In Hong Kong, the Hang Seng Index added 0.3%, ending the day at 22,268. In China, the Shanghai Composite Index rose 0.1% to 3,179 and in Japan, the Nikkei Index closed up 0.6% at 9,871. Shares in Chinese drug companies soared as the number of reported swine flu cases...

    By Peter Cohan

    | 3:00PM 11/06/2009
    When it comes to allocating scarce public resources, large corporations seem to have the upper hand in the US. We already know that many powerful companies, particularly the Wall Street investment banks, having gotten plenty of Washington cash. Now it looks like they're getting first dibs on the...

    By Barbara Bartlein

    | 12:30PM 11/03/2009
    My family has been trying for weeks to get the H1N1 vaccine but the few clinics that have been held around the Milwaukee area have been mobbed. Now we learn that all clinics for the next few weeks are cancelled because there is no vaccine to be had. Even high risk groups such as pregnant women...

    By Lauren Cooper

    | 7:00AM 10/27/2009
    Shares in Asia fell Tuesday, causing the MSCI Asia Pacific Index to post its biggest drop in three weeks. Hong Kong's Hang Seng Index fell 1.9 percent, ending the day at 22,170 and China's Shanghai Composite Index closed at 3,021 – down 2.8 percent. Japan's Nikkei Index slid 1.5 percent to...

    By Melly Alazraki

    | 4:30PM 10/26/2009
    President Obama declared the H1N1 flu outbreak a national emergency last weekend. While U.S. officials insist the move is not a reaction to new developments but a preventive measure, it comes just as the vaccine shortage has been making headlines, with the Centers for Disease Control "frustrated"...